HSBP1P2

Across TCGA pan-cancer cohorts, HSBP1P2 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated HSBP1P2 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher HSBP1P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated HSBP1P2 expression acts as an unfavorable survival marker, although some lineages such as LUSC and SARC show a favorable association.

UCS, KIRC, and UVM are the cancer types where HSBP1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	II,III,IV	0.163	0.567	.001	90	view →
KIRC	OS	Quartile	All	0.452	0.686	<.001	55	view →
UVM	OS	Tertile	All	0.280	0.796	<.001	54	view →
THYM	OS	Tertile	III,IV	0.615	1.000	.019	36	view →
CHOL	OS	Tertile	II,III,IV	0.019	0.765	.001	36	view →
THCA	DFS	Tertile	IV	0.478	0.911	<.001	33	view →
LGG	OS	Tertile	All	0.418	0.543	.029	15	view →
LUSC	OS	Tertile	II,III,IV	0.528	0.339	.023	15	view →
READ	OS	Tertile	IV	0.455	0.824	.005	12	view →
SARC	OS	Tertile	All	0.911	0.797	.026	9	view →
MESO	OS	Tertile	IV	0.134	0.629	.002	9	view →
COAD	DFS	Quartile	All	0.787	0.462	.021	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

HSBP1P2–UCS (OS)

Open the UCS breakdown →